Vinpocetine Inhibits NF-κB-dependent Inflammation in Acute Ischemic Stroke Patients

Clinical trial NCT02878772 · COMPLETED

Trial details

NCT number: NCT02878772
Sponsor: Tianjin Medical University General Hospital
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Stroke Immunoregulation Inflammation Vinpocetine

Start date: 2014-05-01
Primary completion: 2015-12-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.